135 related articles for article (PubMed ID: 31647596)
1. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
Liang Y; Zhou R; Liang X; Kong X; Yang B
Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
[TBL] [Abstract][Full Text] [Related]
3. Oxyresveratrol activates parallel apoptotic and autophagic cell death pathways in neuroblastoma cells.
Rahman MA; Bishayee K; Sadra A; Huh SO
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):23-36. PubMed ID: 27815218
[TBL] [Abstract][Full Text] [Related]
4. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
Li J; Guo C; Lu X; Tan W
Eur J Pharmacol; 2019 Sep; 858():172483. PubMed ID: 31233753
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
Huang C; Li R; Shi W; Huang Z
Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
[TBL] [Abstract][Full Text] [Related]
6. Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis.
Liu Y; Ren W; Bai Y; Wan L; Sun X; Liu Y; Xiong W; Zhang YY; Zhou L
J Nat Med; 2018 Mar; 72(2):481-492. PubMed ID: 29350326
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
8. Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma.
Tan J; Qin X; Liu B; Mo H; Wu Z; Yuan Z
Biomed Pharmacother; 2020 Jun; 126():110096. PubMed ID: 32179199
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-related biotargets and network mechanisms of fucoidan against colorectal cancer: An integrated bioinformatic and experimental approach.
Liu J; Meng Y; Li B; Wang P; Wan X; Huang W; Li R
Int J Biol Macromol; 2022 Dec; 222(Pt A):1522-1530. PubMed ID: 36195230
[TBL] [Abstract][Full Text] [Related]
10. Anti-Colorectal Cancer Mechanisms of Formononetin Identified by Network Pharmacological Approach.
Zhang L; Gong Y; Wang S; Gao F
Med Sci Monit; 2019 Oct; 25():7709-7714. PubMed ID: 31608899
[TBL] [Abstract][Full Text] [Related]
11. Exploring anti-liver cancer targets and mechanisms of oxyresveratrol:
Zhao F; Qin J; Liang Y; Zhou R
Bioengineered; 2021 Dec; 12(2):9939-9948. PubMed ID: 34592904
[TBL] [Abstract][Full Text] [Related]
12. Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data.
Li R; Ma X; Song Y; Zhang Y; Xiong W; Li L; Zhou L
J Cell Biochem; 2019 Jul; 120(7):11265-11273. PubMed ID: 30719773
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of colorectal cancer patients and anti-neoplasm activity of genistein.
Chen X; Gu J; Wu Y; Liang P; Shen M; Xi J; Qin J
Biomed Pharmacother; 2020 Apr; 124():109835. PubMed ID: 31958764
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules.
Buhrmann C; Shayan P; Goel A; Shakibaei M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953264
[TBL] [Abstract][Full Text] [Related]
15. Scutellaria Barbata D Don Inhibits Colorectal Cancer Growth via Suppression of Multiple Signaling Pathways.
Lin J; Chen Y; Cai Q; Wei L; Zhan Y; Shen A; Sferra TJ; Peng J
Integr Cancer Ther; 2014 May; 13(3):240-8. PubMed ID: 24231788
[TBL] [Abstract][Full Text] [Related]
16. Network analysis, and human and animal studies disclose the anticystitis glandularis effects of vitamin C.
Ge B; Guo C; Liang Y; Liu M; Wu K
Biofactors; 2019 Nov; 45(6):912-919. PubMed ID: 31469455
[TBL] [Abstract][Full Text] [Related]
17. Genistein exerts anti-colorectal cancer actions: clinical reports, computational and validated findings.
Liu X; Lan Y; Zhang L; Ye X; Shen Q; Mo G; Chen X
Aging (Albany NY); 2023 May; 15(9):3678-3689. PubMed ID: 37155147
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer targets of formononetin and molecular mechanisms in osteosarcoma: Findings of bioinformatic and experimental assays.
Hu W; Wu X; Tang J; Zhao G; Xiao N; Zhang L; Li S
J Cell Mol Med; 2019 May; 23(5):3505-3511. PubMed ID: 30873755
[TBL] [Abstract][Full Text] [Related]
19. Integrated Network Pharmacology Analysis and
Yang H; Cheung MK; Yue GG; Leung PC; Wong CK; Lau CB
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641576
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
